Relative Dose Intensity of Trabectedin and Outcome of Advanced L‐Sarcomas
This retrospective study does not support a link between high trabectedin RDI and PFS or OS for advanced L-sarcoma patients.
Authors
- Loïc Lebellec (ORCID: https://orcid.org/0000-0002-6079-0185)
- Thomas Ryckewaert
- Marie‐Cécile Le Deley (ORCID: https://orcid.org/0000-0002-2946-4592)
- Jean‐Yves Blay (ORCID: https://orcid.org/0000-0001-7190-120X)
- Nicolas Penel (ORCID: https://orcid.org/0000-0001-5243-1548)
- Simon Nannini (ORCID: https://orcid.org/0000-0003-3097-727X)
- Clémence Leguillette
- Christophe Perrin (ORCID: https://orcid.org/0000-0002-2989-5296)
- Mehdi Brahmi (ORCID: https://orcid.org/0000-0001-9904-166X)
- Emmanuelle Bompas (ORCID: https://orcid.org/0000-0003-4414-7760)
- Jean‐Emmanuel Kurtz (ORCID: https://orcid.org/0000-0003-4611-5797)
- Romain Ould-Ammar
- Stephen Poitureau
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université de Lille (FR)
- Université Paris-Saclay (FR)
- Institut de Cancérologie Strasbourg (FR)
- Lille’s Cardiology Hospital (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Centre Léon Bérard (FR)
- Institut de Cancérologie de l'Ouest (FR)
- Centre Eugène Marquis (FR)
- Centre Oscar Lambret (FR)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1002/cam4.71131
- Citations
- 4
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.07